Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.000
+0.105 (5.54%)
At close: Mar 6, 2026, 4:00 PM EST
1.960
-0.040 (-2.00%)
After-hours: Mar 6, 2026, 7:57 PM EST
Editas Medicine Employees
Editas Medicine had 246 employees as of December 31, 2024. The number of employees decreased by 19 or -7.17% compared to the previous year.
Employees
246
Change (1Y)
-19
Growth (1Y)
-7.17%
Revenue / Employee
$188,549
Profits / Employee
-$812,337
Market Cap
195.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 166 |
| Molecular Partners AG | 153 |
| Heron Therapeutics | 128 |
| Tenaya Therapeutics | 97 |
| Compugen | 74 |
| Cartesian Therapeutics | 66 |
| SAB Biotherapeutics | 63 |
| Tiziana Life Sciences | 9 |
EDIT News
- 11 days ago - Editas Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Genflow Biosciences PLC Announces Directorate Change - Accesswire
- 4 months ago - Editas Medicine Announces Third Quarter 2025 Results and Business Updates - GlobeNewsWire
- 4 months ago - Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025 - GlobeNewsWire
- 5 months ago - Editas Medicine: Three Strikes And It's Out, Or Third Time's The Charm? - Seeking Alpha
- 5 months ago - Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress - GlobeNewsWire
- 5 months ago - Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Editas Medicine, Inc. - Special Call - Seeking Alpha